1 | TCERG1
|
| Specific interaction of the transcription elongation regulator TCERG1 with RNA polymerase II requires simultaneous phosphorylation at Ser2, Ser5, and Ser7 within the carboxyl-terminal domain repeat.
|
| Liu J, Fan S, Lee CJ, Greenleaf AL, Zhou P.
|
| J Biol Chem 288(15):10890-901. doi: 10.1074/jbc.M113.460238. Epub 2013 Feb 22.
2013
|
2 | BCL2L1, TCERG1
|
| TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.
|
| Montes M, Cloutier A, Sánchez-Hernández N, Michelle L, Lemieux B, Blanchette M, Hernández-Munain C, Chabot B, Suñé C.
|
| Mol Cell Biol 32(4):751-62. doi: 10.1128/MCB.06255-11. Epub 2011 Dec 12.
2012
|
3 | TCERG1
|
| The FF4 and FF5 domains of transcription elongation regulator 1 (TCERG1) target proteins to the periphery of speckles.
|
| Sánchez-Hernández N, Ruiz L, Sánchez-Álvarez M, Montes M, Macias MJ, Hernández-Munain C, Suñé C.
|
| J Biol Chem 287(21):17789-800. doi: 10.1074/jbc.M111.304782. Epub 2012 Mar 27.
2012
|
4 | TCERG1
|
| Chemical synthesis of the third WW domain of TCERG 1 by native chemical ligation.
|
| Fidan Z, Younis A, Schmieder P, Volkmer R.
|
| J Pept Sci 17(9):644-9. doi: 10.1002/psc.1383. Epub 2011 Jun 10.
2011
|
5 | TCERG1, UBE2I
|
| Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1).
|
| Sánchez-Alvarez M, Montes M, Sánchez-Hernández N, Hernández-Munain C, Suñé C.
|
| J Biol Chem 285(20):15220-33. Epub 2010 Mar 9.PMID: 20215116 2010
|
6 | CEBPA, TCERG1
|
| Nuclear redistribution of TCERG1 is required for its ability to inhibit the transcriptional and anti-proliferative activities of C/EBPalpha.
|
| Banman SL, McFie PJ, Wilson HL, Roesler WJ.
|
| J Cell Biochem 109(1):140-51. doi: 10.1002/jcb.22391.
2010
|
7 | TCERG1
|
| Identification of the cellular targets of the transcription factor TCERG1 reveals a prevalent role in mRNA processing.
|
| Pearson JL, Robinson TJ, Mu–oz MJ, Kornblihtt AR, Garcia-Blanco MA.
|
| J Biol Chem 283(12):7949-61. Epub 2008 Jan 10. 2008
|
8 | TCERG1
|
| Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.
|
| Andresen JM, Gay‡n J, Cherny SS, Brocklebank D, Alkorta-Aranburu G, Addis EA; US-Venezuela Collaborative Research Group, Cardon LR, Housman DE, Wexler NS.
|
| J Med Genet 44(1):44-50. Epub 2006 Oct 3. 2007
|
9 | TCERG1
|
| Human transcription elongation factor CA150 localizes to splicing factor-rich nuclear speckles and assembles transcription and splicing components into complexes through its amino and carboxyl regions.
|
| S‡nchez-Alvarez M, Goldstrohm AC, Garcia-Blanco MA, Su–Ž C.
|
| Mol Cell Biol 26(13):4998-5014. 2006
|
10 | UBE2K, PACSIN1, ZDHHC17, TAF4, TRIP10, DLG4, SH3GL3, TCERG1, CTBP1, GAPDH
|
| Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
|
| Li SH, Li XJ.
|
| Trends Genet 20(3):146-54. Review. 2004
|
11 | TCERG1
|
| FF domains of CA150 bind transcription and splicing factors through multiple weak interactions.
|
| Smith MJ, Kulkarni S, Pawson T.
|
| Mol Cell Biol 24(21):9274-85. 2004
|
12 | TCERG1
|
| The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis.
|
| Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C, Hayden MR, Margolis RL, Ross CA, Dausset J, Ferrante RJ, Neri C.
|
| Proc Natl Acad Sci U S A 98(4):1811-6. 2001
|
13 | TCERG1
|
| Expression analysis and mapping of the mouse and human transcriptional regulator CA150.
|
| Bohne J, Cole SE, Sune C, Lindman BR, Ko VD, Vogt TF, Garcia-Blanco MA.
|
| Mamm Genome 11(10):930-3. No abstract available. 2000
|
14 | TCERG1
|
| CA150, a nuclear protein associated with the RNA polymerase II holoenzyme, is involved in Tat-activated human immunodeficiency virus type 1 transcription.
|
| Sune C, Hayashi T, Liu Y, Lane WS, Young RA, Garcia-Blanco MA.
|
| Mol Cell Biol 17(10):6029-39. 1997
|